Cargando…
2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury
Histone deacetylases 6 (HDAC6) has been reported to be involved in the pathogenesis of cisplatin-induced acute kidney injury (AKI). Selective inhibition of HDAC6 might be a potential treatment for AKI. In our previous study, a highly selective HDAC6 inhibitor (HDAC6i) 23BB effectively protected agai...
Autores principales: | Hao, Yan, Guo, Fan, Huang, Zhuo, Feng, Yuying, Xia, Zijing, Liu, Jing, Li, Lingzhi, Huang, Rongshuang, Lin, Lin, Ma, Liang, Fu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970081/ https://www.ncbi.nlm.nih.gov/pubmed/31894849 http://dx.doi.org/10.1042/BSR20191538 |
Ejemplares similares
-
Selective Histone Deacetylase 6 Inhibitor 23BB Alleviated Rhabdomyolysis-Induced Acute Kidney Injury by Regulating Endoplasmic Reticulum Stress and Apoptosis
por: Feng, Yuying, et al.
Publicado: (2018) -
2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury
por: Liu, Jing, et al.
Publicado: (2019) -
Pharmacological and genetic inhibition of fatty acid‐binding protein 4 alleviated cisplatin‐induced acute kidney injury
por: Tan, Zhouke, et al.
Publicado: (2019) -
Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors
por: Moreaux, J, et al.
Publicado: (2013) -
Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis
por: Winkler, Robin, et al.
Publicado: (2012)